PCN24 Disease-Free Survival (DFS) As a Surrogate Endpoint for Overall Survival (OS) in HER2 Negative (HER2–) Primary Breast Cancer (BC)

Abstract

Authors

C. McCrea I. Chatzidaki E. Drane E. McArthur S. Beaver T. Reason P. Gulati

Full Text Cite This Article
Back to Volume 23, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×